Elsevier

The Lancet

Volume 322, Issue 8364, 17 December 1983, Pages 1429-1430
The Lancet

Letters to the Editor
DANGEROUS HYPOXAEMIA DURING CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT OF OBSTRUCTIVE SLEEP APNOEA

https://doi.org/10.1016/S0140-6736(83)90966-2Get rights and content

References (4)

There are more references available in the full text version of this article.

Cited by (47)

  • Positive airway pressure II: Settings and outcomes

    2020, Obesity Hypoventilation Syndrome: From Physiologic Principles to Clinical Practice
  • Positive-pressure treatment of obstructive sleep apnea syndrome

    2011, Handbook of Clinical Neurology
    Citation Excerpt :

    In this chapter, these data are summarized with emphasis on the practical use of CPAP therapy in clinical management of OSAS patients. Nasal CPAP therapy for sleep apnea was first described in 1981 (Sullivan et al., 1981), but there was initial skepticism of its efficacy and concern regarding its potential adverse effects on breathing (Krieger et al., 1983; Wagner et al., 1983). However, there was also early recognition of the importance of having a treatment that could essentially prevent disordered breathing during sleep in contrast to partial or variable response to surgery (Bradley and Phillipson, 1983).

  • Medical Therapy for Obstructive Sleep Apnea

    2010, Principles and Practice of Sleep Medicine: Fifth Edition
  • Positive Airway Pressure in the Treatment of Sleep Apnea-Hypopnea

    2009, Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects: Third Edition
  • Medical Therapy for Obstructive Sleep Apnea-Hypopnea Syndrome

    2005, Principles and Practice of Sleep Medicine
View all citing articles on Scopus
View full text